Ahmad Haidar

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications

Transient Benign Ketosis Is Common in Type 1 Diabetes During Very-Low Carbohydrate States: Novel Data from Continuous Ketone Sensor.

Transient Benign Ketosis Is Common in Type 1 Diabetes During Very-Low Carbohydrate States: Novel Data from Continuous Ketone Sensor.

Journal: Diabetes technology & therapeutics
Published: July 01, 2026

Comparing Automated Lyumjev® Delivery with Carbohydrate Counting, Qualitative Meal-Size Estimation, and Fully Closed-Loop in Type 1 Diabetes: A Pilot, Randomized, Crossover Trial.

Comparing Automated Lyumjev® Delivery with Carbohydrate Counting, Qualitative Meal-Size Estimation, and Fully Closed-Loop in Type 1 Diabetes: A Pilot, Randomized, Crossover Trial.

Journal: Diabetes technology & therapeutics
Published: June 10, 2026

Author Correction: A Bayesian decision support system for automated insulin doses in adults with type 1 diabetes on multiple daily injections: a randomized controlled trial.

Author Correction: A Bayesian decision support system for automated insulin doses in adults with type 1 diabetes on multiple daily injections: a randomized controlled trial.

Journal: Nature communications
Published: April 17, 2026

Continuous Ketone Monitoring Captures Overt Ketosis in Type 1 Diabetes Caused by Empagliflozin, Low-Carbohydrate Diet, and Exercise.

Continuous Ketone Monitoring Captures Overt Ketosis in Type 1 Diabetes Caused by Empagliflozin, Low-Carbohydrate Diet, and Exercise.

Journal: Diabetes technology & therapeutics
Published: February 05, 2026

Semaglutide and cardiovascular risk in type 1 diabetes: A predictive modelling analysis in a double-blind, randomised, placebo-controlled cross-over trial.

Semaglutide and cardiovascular risk in type 1 diabetes: A predictive modelling analysis in a double-blind, randomised, placebo-controlled cross-over trial.

Journal: Diabetes, obesity & metabolism
Published: December 17, 2025

A Pilot Outpatient Assessment of a Fully Closed-Loop Insulin and Pramlintide System.

A Pilot Outpatient Assessment of a Fully Closed-Loop Insulin and Pramlintide System.

Journal: Journal of diabetes science and technology
Published: November 01, 2025

Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post-hoc analysis of a double-blinded, randomised, crossover trial.

Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post-hoc analysis of a double-blinded, randomised, crossover trial.

Journal: Diabetes, obesity & metabolism
Published: August 19, 2025

Semaglutide withdrawal in adults with type 1 diabetes on pump therapy: A post-hoc analysis from a double-blinded randomized controlled trial.

Semaglutide withdrawal in adults with type 1 diabetes on pump therapy: A post-hoc analysis from a double-blinded randomized controlled trial.

Journal: Diabetes, obesity & metabolism
Published: August 12, 2025

Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology.

Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology.

Journal: The lancet. Diabetes & endocrinology
Published: August 08, 2025

Additive Benefits of Control-IQ+ AID to GLP-1 Receptor Agonist Use in Adults With Type 2 Diabetes.

Additive Benefits of Control-IQ+ AID to GLP-1 Receptor Agonist Use in Adults With Type 2 Diabetes.

Journal: Diabetes care
Published: July 18, 2025

Early Stages of Automated Insulin Delivery.

Early Stages of Automated Insulin Delivery.

Journal: Journal of diabetes science and technology
Published: July 01, 2025

Early Stages of Automated Insulin Delivery.

Early Stages of Automated Insulin Delivery.

Journal: Diabetes technology & therapeutics
Published: July 01, 2025
Showing 1-12 of 80

Last Updated: 09/26/2026